Sign in

NCT04159324Completed

StroCare - Optimised Cross-sectoral,Coordinated Treatment of Stroke Patients With Patient-orientated Outcome Measurement

StroCare - Optimised Cross-sectoral, Coordinated Treatment of Stroke Patients With Patient-orientated Outcome Measurement

Source: ClinicalTrials.gov · Last updated 29 Dec 2023

Brief summary (registry, in English)

The Trial is a multi-centred controlled interventional study with a pre-post design. The primary aim of the study is the evaluation of the effectiveness and cost-effectiveness of the StroCare treatment.

Status (registry)
Completed
Study type
Interventional
Enrollment
409 (actual)
First submitted
7 Nov 2019
Start date
1 Jan 2020
Primary completion date
5 Dec 2023
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Diseases
Stroke
NCT number
NCT04159324

What you commit to

  • Study type: Interventional
  • Participants enrolled: 409
  • From 1 Jan 2020 to the primary completion date, 5 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Substantially impaired communication capacity due to aphasia or dementia
  • Dementia (F00.x., F01.x. or G30.x) or aphasia (R47)

Other

  • Patients with artificial Respiration
  • Insufficient adherence
  • Premorbid score of mRS≥4
  • Patients with artificial Respiration (Z99.1)
  • Death during inpatient Treatment or the Admission to a nursing home following the acute treatment

Who the study is looking for

  • Patients in inpatient care in the stroke unit of one of the participating acute clinics who are insured at the BARMER health insurance agency with the following diagnosis (ICD-10):
  • Ischemic attack (I63)
  • Transient ischemic attack and related syndromes (G45)
  • Intracerebral haermorrhage (I64)
  • Written informed consent
  • Sufficient mastery of German language

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Medical Center Hamburg-Eppendorf
Coordinator of this site? Confirm its status
HamburgGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.